discontinued (Figure 5 For adults taking OP therapy and discontinuing GC therapy, with no new fragility fracture and a current BMD t-score â‰¥-2.5, we strongly recommended stopping current OP therapy and continuing calcium and vitamin D. However, sequential therapy is strongly recommended after stopping DEN, PTH/PTHrP, and ROM (Figure 5 This recommendation is based on low-certainty evidence and on the balance of benefits and harms of continued treatment with OP medication. BP and RAL can be